Researchers should combine thematic coding of short survey answers and interview notes with cross-segment quantitative comparisons to design targeted psychosocial supports. The PLOS One study (June 26, 2026) reported that 63.0% of 146 Turkish IBD patients endorsed at least one stigma-related item, mostly social avoidance (45.9%) and public discomfort (36.3%) PLOS One. This post explains how to reproduce and extend those findings with AI-enabled qualitative research: extract themes, compare segments (age, disease subtype, self-esteem), and produce clinician-ready visuals. If you want to go from raw responses to a stakeholder report in days rather than weeks, see how to apply the study methods and where this platform speeds the work while keeping data private.
Key Takeaways
The PLOS One study (June 26, 2026) found 63.0% of 146 IBD patients reported at least one stigma experience, concentrated in social avoidance (45.9%) and public discomfort (36.3%). Researchers should pair thematic coding of binary items and free-text with cross-segment comparison (age, disease subtype, RSES) to turn prevalence into targeted interventions. Use AI-assisted workflows to accelerate coding, generate heatmaps and segment comparisons, and produce stakeholder-ready visuals while preserving privacy.
- 63.0% prevalence across n=146, study period Dec 1, 2025 – Jan 10, 2026, stigma defined as ≥1 'Yes' on 10 IBD-specific items (KR-20 = 0.83).
- Primary manifestations were social avoidance (45.9%) and public discomfort (36.3%), suggesting behavioral avoidance is more common than overt discrimination.
- Recommended analytic focus: thematic coding of short disclosures, cross-segment tests by age and RSES, and visual outputs (heatmaps, co-occurrence networks) for stakeholders.
Fast take + source
Fast take: The PLOS One study (June 26, 2026) reported that 63.0% of 146 Turkish IBD patients endorsed at least one stigma-related item, with younger age and lower Rosenberg Self‑Esteem Scale scores independently associated with perceived stigma. Read the original paper at PLOS One.
- Study dates: Dec 1, 2025 – Jan 10, 2026; design: cross-sectional online survey; stigma defined as ≥1 'Yes' on 10 IBD-specific items (KR-20 = 0.83).
- Why analysts care: the paper produces categorical responses and short disclosures ideal for thematic coding, cross-segment comparison, and visualization.
Findings Snapshot
| Metric | Value | Note / Relevance |
|---|---|---|
| Publication date | June 26, 2026 | PLOS One, peer-reviewed |
| Sample size | 146 patients | Cross-sectional outpatient cohort |
| Stigma prevalence | 63.0% | Defined as ≥1 'Yes' to 10 items |
| Top manifestations | Social avoidance 45.9%; Public discomfort 36.3% | Behavioral avoidance > overt discrimination |
| Associated factors | Younger age; lower RSES (median 20.5 vs 23.0; p=0.005) | Useful covariates for segment analyses |
| Scale reliability | KR-20 = 0.83 | Internal consistency of the 10-item set |
Study design & data pipeline (plain English)
Study design: The authors collected data using an online Google Forms survey with four blocks (demographics, disease features, RSES, and 10 binary stigma items). Snowball sampling from a tertiary clinic produced n=146; responses were analyzed with nonparametric tests and a logistic regression (age and RSES entered as continuous variables).
- Stigma items: concrete yes/no questions (e.g., 'Do you avoid social activities because of your IBD? ').
- Visual: authors used a heatmap of affirmative responses (Python seaborn/matplotlib).
- Limitations to note: no standardized IBD stigma scale, cross-sectional design, potential sampling bias (online/snowball).
So what for researchers, clinicians, and UX teams
For qualitative researchers
Qualitative researchers should use this dataset as a model case to triangulate short, binary items with free-text or interview transcripts and move from prevalence to narrative. Use thematic coding to surface why younger patients report more avoidance and compare segments by age-at-diagnosis, disease subtype, and RSES to test hypotheses about disclosure, concealment, and social identity.
For clinical teams and policy analysts
Clinical teams and policy analysts should treat behavioral avoidance (45.9%) as a signal for missed appointments or social withdrawal that may impact adherence, and integrate psychosocial screening into routine visits with targeted interventions for younger patients. Translate analyses into decision-ready visuals (heatmaps, segment comparisons) for multidisciplinary meetings.
For UX & patient-experience teams
UX and patient-experience teams should design pathways that reduce exposure-related anxiety, because stigma drives non-disclosure and hidden needs (11.6% conceal medication). Design privacy cues, discreet medication prompts, and accessible toilet information, and measure intervention impact by repeating the same 10-item instrument and comparing cross-sectional snapshots with AI-assisted thematic summaries.
Do more, faster with Evidano (mapped to this study)
Overview
Evidano is an AI-powered qualitative data analysis platform that automates cleaning, thematic coding, and segment comparison while protecting sensitive health data. The platform maps directly to the study workflow: import, clean, code, compare segments, and export reproducible outputs (codebooks, quotes, and visuals).
Import & prepare
Import and prepare: ingest the survey CSV or interview transcripts directly into Evidano. Auto-clean data, map demographics to segments (age, diagnosis age, subtype), and import the RSES scores as a numeric variable.
Automated thematic + frequency analysis
Automated thematic analysis: run an AI-enabled thematic pass to cluster short disclosures (e.g., 'avoid social activities', 'hesitate to tell others'), producing themes, subcodes, and frequency counts so analysts can quantify behavioral versus enacted stigma quickly.
Cross-segment tests & visuals
Cross-segment comparison: compare prevalence by age, disease type, or self-esteem, and generate heatmaps and co-occurrence networks similar to the paper's heatmap in a click for presentations to clinicians and stakeholders.
Secure sharing & reproducibility
Secure sharing and reproducibility: export reproducible codebooks, clickable quotes, and slide-ready charts. Evidano encrypts your data and does not use customer data to train third-party models, making it suitable for sensitive health datasets.
Two-week workflow: from import to stakeholder memo
Two-week workflow: follow these six steps to go from dataset import to a stakeholder-ready memo. Step 1: Import survey CSV or transcripts into Evidano; map variables (age, diagnosis age, subtype, RSES). Step 2: Run automated cleaning and a first-pass topic model to surface candidate stigma themes. Step 3: Use AI-assisted coding to apply or refine a codebook; validate with 10–15 manual checks. Step 4: Produce cross-segment frequency tables and a heatmap mirroring the paper (stigma items × subgroup). Step 5: Generate an executive memo with top 5 themes, representative quotes (PII redacted), and recommended interventions. Step 6: Share interactive visualizations with clinical and UX stakeholders; schedule targeted qualitative follow-ups using AI avatar interviewers if needed.
FAQ: qualitative analysis of IBD stigma
What is qualitative analysis of IBD stigma and when should I use it?
Qualitative analysis of IBD stigma is the process of extracting themes and narratives from patient reports and interviews to explain why stigma appears and how it affects behavior. Use it when prevalence estimates (like 63.0%) need context for intervention design, and when short binary items or disclosures require thematic interpretation to guide programs.
How do I compare segments reliably?
You should standardize variables and run the same codebook across segments to compare reliably. Standardize age bins and diagnosis age, use frequency and co-occurrence metrics, and apply the same codebook across subgroups; this study highlights age and RSES as useful covariates.
Is this appropriate for sensitive health data?
Yes, qualitative analysis of IBD stigma can be appropriate for sensitive health data when you follow ethics approvals and consent procedures. Use PII redaction, encryption, and platform controls for sharing; the methods described are for research and program design, not clinical diagnosis.
Conclusion, next moves
Conclusion: The PLOS One study (June 26, 2026) shows stigma in IBD is common and concentrated in social discomfort and avoidance, actionable signals for researchers and care teams. Reproduce and expand that work by combining thematic coding with cross-segment analysis to design targeted psychosocial supports. Ready to try this on your dataset? Try Evidano for free. Ethics note: this guidance is research-focused and non-diagnostic; follow local IRB and consent rules for patient data.